Calori, Italo Rodrigo 
; Piva, Henrique Luis ; Tedesco, Antônio Cláudio
Fonte: Journal of Drug Delivery Science and Technology. Unidade: FFCLRP
Assuntos: TERAPIA FOTODINÂMICA, CÉLULAS, NEOPLASIAS, ANTIOXIDANTES, LIPOSSOMOS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALORI, Italo Rodrigo e PIVA, Henrique Luis e TEDESCO, Antônio Cláudio. Targeted cancer therapy using alpha-cyano-4-hydroxycinnamic acid as a novel vector molecule: a proof-of-concept study. Journal of Drug Delivery Science and Technology, v. 57, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2020.101633. Acesso em: 11 nov. 2025.APA
Calori, I. R., Piva, H. L., & Tedesco, A. C. (2020). Targeted cancer therapy using alpha-cyano-4-hydroxycinnamic acid as a novel vector molecule: a proof-of-concept study. Journal of Drug Delivery Science and Technology, 57. doi:10.1016/j.jddst.2020.101633NLM
Calori IR, Piva HL, Tedesco AC. Targeted cancer therapy using alpha-cyano-4-hydroxycinnamic acid as a novel vector molecule: a proof-of-concept study [Internet]. Journal of Drug Delivery Science and Technology. 2020 ; 57[citado 2025 nov. 11 ] Available from: https://doi.org/10.1016/j.jddst.2020.101633Vancouver
Calori IR, Piva HL, Tedesco AC. Targeted cancer therapy using alpha-cyano-4-hydroxycinnamic acid as a novel vector molecule: a proof-of-concept study [Internet]. Journal of Drug Delivery Science and Technology. 2020 ; 57[citado 2025 nov. 11 ] Available from: https://doi.org/10.1016/j.jddst.2020.101633
